Literature DB >> 15832510

A novel hPepT1 stably transfected cell line: establishing a correlation between expression and function.

Dea Herrera-Ruiz1, Teresa N Faria, Rajinder K Bhardwaj, Julita Timoszyk, Olafur S Gudmundsson, Paul Moench, Doris A Wall, Ronald L Smith, Gregory T Knipp.   

Abstract

Stably transfected MDCK/hPepT1-V5&His clonal cell lines expressing varying levels of epitope-tagged hPepT1 protein were established to quantify the relationship between transgene hPepT1 expression levels and its functional kinetics in facilitating peptide and peptide-like drug uptake and transport in vitro. The hPepT1 sequence was amplified from Caco-2 cell mRNA, inserted into the pcDNA3.1 -V5&His TOPO plasmid, and transfected into MDCK cells. Transgene protein levels were quantified by Western Blot analysis utilizing a standard curve generated with a positive control protein containing a V5&His epitope. Three clones expressing different levels of the hPepT1 fusion protein (low, medium, and high) were selected for the functional characterization with [14C]Gly-Sar and [3H]carnosine. The MDCK/hPepT1 cells expressed a novel hPepT1/epitope tag protein with an apparent molecular mass of 110 kDa. The [14C]Gly-Sar uptake in the transfected cells was sodium-independent and pH-dependent, demonstrating enhanced uptake, the rate of which increased significantly from the weakly to strongly expressing hPepT1 MDCK/hPepT1 -V5&His clones as compared to the mock cell line at pH 6.0. The uptake and permeability of [14C]Gly-Sar and [3H]carnosine demonstrated a direct correlation between the hPepT1 level of expression, uptake, and transport capabilities. Molecular and functional characterization of the MDCK/hPepT1-V5&His cell line confirmed a directly proportional relationship between Vmax and Papp versus the molar levels of hPepT1 transgene expression. This stably transfected hPepT1 cell line may serve as a useful in vitro model for screening and quantifying peptide and peptide-like drug transport as a function of hPepT1 expression in drug discovery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15832510     DOI: 10.1021/mp034011l

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  10 in total

1.  Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.

Authors:  Diana Højmark Omkvist; Birger Brodin; Carsten Uhd Nielsen
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

2.  THE EVALUATION OF PEPTIDE/HISTIDINE TRANSPORTER 1 (PHT1) FUNCTION: UPTAKE KINETICS UTILIZING A COS-7 STABLY TRANSFECTED CELL LINE.

Authors:  David J Lindley; Stephen M Carl; Stephanie A Mowery; Gregory T Knipp
Journal:  Rev Mex Cienc Farm       Date:  2011-10

3.  A quantitative structure-activity relationship for translocation of tripeptides via the human proton-coupled peptide transporter, hPEPT1 (SLC15A1).

Authors:  Diana Højmark Omkvist; Simon Birksø Larsen; Carsten Uhd Nielsen; Bente Steffansen; Lars Olsen; Flemming Steen Jørgensen; Birger Brodin
Journal:  AAPS J       Date:  2010-05-08       Impact factor: 4.009

4.  Functional Characterization of Human Peptide/Histidine Transporter 1 in Stably Transfected MDCK Cells.

Authors:  Feifeng Song; Yongjun Hu; Yuqing Wang; David E Smith; Huidi Jiang
Journal:  Mol Pharm       Date:  2018-01-02       Impact factor: 4.939

5.  The effects of intralaboratory modifications to media composition and cell source on the expression of pharmaceutically relevant transporters and metabolizing genes in the Caco-2 cell line.

Authors:  Wyatt J Roth; David J Lindley; Stephen M Carl; Gregory T Knipp
Journal:  J Pharm Sci       Date:  2012-07-11       Impact factor: 3.534

6.  Differentiating passive from transporter-mediated uptake by PepT1: a comparison and evaluation of four methods.

Authors:  Jeffrey S Scow; Srivats Madhavan; Rizwan M Chaudhry; Ye Zheng; Judith A Duenes; Michael G Sarr
Journal:  J Surg Res       Date:  2011-03-12       Impact factor: 2.192

7.  Delta-aminolevulinic acid is a substrate for the amino acid transporter SLC36A1 (hPAT1).

Authors:  S Frølund; O C Marquez; M Larsen; B Brodin; C U Nielsen
Journal:  Br J Pharmacol       Date:  2010-01-27       Impact factor: 8.739

8.  Development of stably transfected monolayer overexpressing the human apical sodium-dependent bile acid transporter (hASBT).

Authors:  Anand Balakrishnan; Daniel J Sussman; James E Polli
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

9.  Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data.

Authors:  Alexander Aliper; Sergey Plis; Artem Artemov; Alvaro Ulloa; Polina Mamoshina; Alex Zhavoronkov
Journal:  Mol Pharm       Date:  2016-06-08       Impact factor: 4.939

10.  Expression Profile of Drug and Nutrient Absorption Related Genes in Madin-Darby Canine Kidney (MDCK) Cells Grown under Differentiation Conditions.

Authors:  Yong Quan; Yisheng Jin; Teresa N Faria; Charles A Tilford; Aiqing He; Doris A Wall; Ronald L Smith; Balvinder S Vig
Journal:  Pharmaceutics       Date:  2012-06-18       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.